Puzzle in Wednesday order on duty exemption
One of the 3 reversals on removal of customs concession is for a drug whose Sun Pharma generic is market leader19-02-2016
19-02-2016
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Sudhir V Valia has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE18-02-2016
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Virtuous Finance Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE16-02-2016
India Inc bats for 'skill corridor' in Maharashtra
Skilling of people to use new technology in manufacturing should be encouraged, said Sun Pharma MD Dilip Shanghvi15-02-2016
Sun Pharma: good quarter, but waiting for answers on Halol
Sun Pharmas remediation efforts at the Halol plant held back US sales growth, as did competitive pressure14-02-2016
Sun Pharma to seek FDA re-inspection of Halol plant by end-June
Sun Pharma plans to ask US FDA by the middle of this year to re-inspect Gujarats Halol plant after they criticised manufacturing standards there13-02-2016
Updates
Sun Pharmaceutical Industries Ltd has informed BSE regarding "Wind down/Termination of the Collaboration Established in 2011 between affiliates of Merck Sharp & Dohme and Sun Pharmaceutical Industries Limited to Develop and Commercialize Novel Formulations and Combinations of Medicines for Emerging Markets".12-02-2016
Results Press Release for December 31, 2015
Sun Pharmaceutical Industries Ltd has informed BSE about : 1. Result Press Release for the period ended December 31, 201512-02-2016
Sun Pharma Q3 net profit rises to Rs1,417 crore
Net sales rises to Rs7,046.57 crore for the third quarter as against Rs6,885.46 crore in the same period of previous fiscal12-02-2016
Announces Q3 Results (Standalone & Consolidated) & Limited Review Report (Standalone & Consolidated) for the Quarter ended December 31, 2015
Sun Pharmaceutical Industries Ltd has announced the following results for the quarter ended December 31, 2015 :The Un-Audited Standalone results for the Quarter ended December 31, 2015The Company has posted a net loss of Rs. (1466.50) million for the quarter ended December 31, 2015 as compared to net loss of Rs. (15115.90) million for the quarter ended December 31, 2014. Total Income has increased from Rs. 14857.40 million for the...12-02-2016